Steroidogenesis inhibitor

From WikiMD's WELLNESSPEDIA
HMG-CoA_reductase_pathway.svg

Steroidogenesis inhibitor

A steroidogenesis inhibitor is a type of drug that inhibits the biosynthesis of steroids. These inhibitors are used in the treatment of various medical conditions, including Cushing's syndrome, prostate cancer, and breast cancer. They work by blocking the activity of enzymes involved in the steroidogenesis pathway, thereby reducing the production of steroid hormones.

Mechanism of Action[edit]

Steroidogenesis inhibitors target specific enzymes in the steroid biosynthesis pathway. Key enzymes that are often targeted include:

By inhibiting these enzymes, the production of various steroid hormones such as cortisol, androgens, and estrogens is reduced.

Clinical Uses[edit]

Steroidogenesis inhibitors are used in the treatment of several conditions:

  • Cushing's syndrome: Excessive production of cortisol can be managed by inhibiting steroidogenesis.
  • Prostate cancer: Androgen deprivation therapy often includes the use of steroidogenesis inhibitors to reduce androgen levels.
  • Breast cancer: Aromatase inhibitors are used to lower estrogen levels in hormone receptor-positive breast cancer.

Common Steroidogenesis Inhibitors[edit]

Some commonly used steroidogenesis inhibitors include:

  • Ketoconazole: An antifungal agent that also inhibits several enzymes in the steroidogenesis pathway.
  • Metyrapone: Primarily used in the diagnosis and treatment of Cushing's syndrome.
  • Aminoglutethimide: Inhibits the conversion of cholesterol to pregnenolone, affecting the production of all steroid hormones.
  • Abiraterone: Used in the treatment of prostate cancer by inhibiting CYP17A1.

Side Effects[edit]

The use of steroidogenesis inhibitors can lead to various side effects due to the reduced production of steroid hormones. Common side effects include:

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.